No significant BARC type 3 bleeding events (reduction in Hb, intracranial hemorrhage, intraocular hemorrhage, blood transfusion urgency), BARC type 4 bleeding events (CABG‐related bleeding events) nor BARC type 5 bleeding events (fatal bleeding) was recorded in either group. The gene discussed is GSTM1; the disease is intracranial hemorrhage.